Technology platform licensing

Licensing opportunities available

iCRT-deter offers a platform solution for the controlled release of potent and addictive compounds, including opioids. With abuse deterrent properties, and tailored release of active ingredients, iCRT-deter can help protect the patient and the product.

Partnering with Lucideon will offer:

  • Formulation consultancy and development trials.
  • Access to licensing rights.
  • Product IP extension.

Through decades of partnership and collaboration we’ve learned that nothing accelerates R&D better than working together, and Lucideon adds value through partnership in more ways than one.

Partnering – innovation through collaboration:

  • Exploit novel technology platforms.
  • Focus your R&D.
  • Accelerate your time to market.
  • Boost your organization’s innovation.

Contact us

(US) +1-919-504-4900

(UK) +44 (0)1782 764389